Maraviroc Tablet, Film Coated
Product Images NDC 68554-3079

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 68554-3079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hetero Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Maraviroctablet150mglabel (Maraviroctablet150mglabel)

This is an information package for Maraviroc tablets containing 150 mg of the active ingredient. The usual dosage information is provided in the package insert, and it is advised to store the tablets at a temperature between 20° to 25°C. The tablets should be dispensed in tight containers. The contact number for US inquiries is 866-495-1995. The tablets are identified by NDC 68554-3079-0. The manufacturer of the tablets is Hetero Labs Limited, located in Hyderabad, India.*

FDA Label Image

Maraviroctablet300mglabel (Maraviroctablet300mglabel)

This text contains information about Maraviroc Tablets, each tablet containing 300 mg of maraviroc. It provides guidelines for storage, dosage, dispensing, and contact information. The tablets should be stored at 20° to 25°C. It also includes a US contact number for inquiries. The text mentions dispensing in tight containers and the requirement to dispense with an attached Medication Guide to each patient. Additionally, it includes manufacturing details, indicating that the tablets are manufactured by HETERO™ at HETERO LABS LIMITED in Hyderabad, India.*

FDA Label Image

Maraviroctabletstructure (Maraviroctabletstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.